HR 2821 · 119th Congress · Health

FDA Modernization Act 3.0

Introduced 2025-04-10· Sponsored by Rep. Carter, Earl L. "Buddy" [R-GA-1]· House

Bill Progress

Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the House Committee on Energy and Commerce.(2025-04-10)

Plain Language Summary

[AI summary unavailable — showing source text] [Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 2821 Introduced in House (IH)] <DOC> 119th CONGRESS 1st Session H. R. 2821 To require the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to publish a final rule relating to nonclinical testing methods. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES April 10, 2025 Mr. Carter of Georgia (for himself, Ms. Barragan, Mr. Buchanan, Ms. DeLauro, Mrs. Harshbarger, and Mr. Carter of Louisiana) introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To require the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to publish a final rule relating to nonclinical testing methods. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``FDA Modernization Act 3.0''. SEC. 2. REGULATIONS ON NONCLINICAL TESTING METHODS. (a) Interim Final Rule.-- (1)…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (20)

12 Democrats8 Republicans